Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04789317 · ClinicalTrials.gov registry record
Pullback Pressure Gradient (PPG) Global Registry
A clinical trial of Chronic Coronary Insufficiency and Non ST Elevation Myocardial Infarction, sponsored by VZW Cardiovascular Research Center Aalst.
- Active
- Registry status
- 982
- Enrollment target
- 20
- Study locations
NCT04789317: Active study of Chronic Coronary Insufficiency and Non ST Elevation Myocardial Infarction, sponsored by VZW Cardiovascular Research Center Aalst.
NCT04789317 is a study of Chronic Coronary Insufficiency and Non ST Elevation Myocardial Infarction that is active but no longer recruiting, run by VZW Cardiovascular Research Center Aalst. The registered enrollment target is 982 participants. The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04789317, a study of Chronic Coronary Insufficiency and Non ST Elevation Myocardial Infarction, is active but no longer recruiting, sponsored by VZW Cardiovascular Research Center Aalst.
- ACTIVE NOT RECRUITING
- Registry status
- 982 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine the predictive capacity of the Pullback Pressure Gradient (PPG) index for post-PCI FFR and to determine the impact of the PPG index on clinical decision making about revascularization and on clinical outcomes.
Primary Outcome
Describe the relationship between pre PCI PPG and post-PCI FFR
Conditions Studied
Study Locations (20)
Other
- Monash Medical Center - Melbourne
- Concord Repatriation General Hospital - Sydney
- OLV Aalst - Aalst
- Aalborg University Hospital - Aalborg
- Aarhus University Hospital - Aarhus
- Righospitalet - Copenhagen
- Institut Arnault Tzanck - Nice
- Ferrara University - Ferrara
- Fondazione Policlinico Universitario A. Gemelli IRCCS - Rome
- Aichi University - Aichi
- Gifu Heart Center - Gifu
- Showa University Hospital - Tokyo
- Tokyo D Tower Hospital - Tokyo
- Catharina Ziekenhuis - Eindhoven
- Radboud UMC - Nijmegen
- Hospital Clinico San Carlos - Madrid
- Hospital Universitario de La Princesa - Madrid
California
- Stanford University - Stanford
New York
- St Francis Hospital and Heart Center - New York
Texas
- Memorial Hermann Texas Medical Center - Texas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 982 participants |
| Start Date | 2020-12-23 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT04789317 still lists
NCT04789317 is an observational study that tracks outcomes without assigning an intervention. The registered 982 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Chronic Coronary Insufficiency appearing as the primary indexed condition, and to 0 interventions.
NCT04789317 names 20 study sites across 4 states, led by Other, California, New York.
Frequently Asked Questions
What is clinical trial NCT04789317 about?
NCT04789317 is a clinical study titled "Pullback Pressure Gradient (PPG) Global Registry". The purpose of this study is to determine the predictive capacity of the Pullback Pressure Gradient (PPG) index for post-PCI FFR and to determine the impact of the PPG index on clinical decision making about revascularization and on clinical outcomes.
What is the current status of trial NCT04789317?
This trial is currently active not recruiting. The enrollment target is 982 participants. The study started on 2020-12-23. Estimated completion is 2026-12-31.
What conditions does trial NCT04789317 study?
This clinical trial studies the following conditions: Chronic Coronary Insufficiency, Non ST Elevation Myocardial Infarction.
Who is sponsoring clinical trial NCT04789317?
This trial is sponsored by VZW Cardiovascular Research Center Aalst, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04789317 being conducted?
This trial has 20 study locations across California, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06989437 · 982 participants · Phase 2
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- NCT06959095 · 981 participants · Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- NCT06337097 · 980 participants · NA
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
- NCT07070232 · 980 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI